Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

CareRx Corp

Healthcare CA CRRX

3.6CAD
-0.04(1.10%)

Last update at 2026-03-10T20:00:00Z

Day Range

3.483.67
LowHigh

52 Week Range

2.324.00
LowHigh

Fundamentals

  • Previous Close 3.64
  • Market Cap244.89M
  • Volume51101
  • P/E Ratio390.00
  • Dividend Yield0.51%
  • EBITDA20.48M
  • Revenue TTM366.34M
  • Revenue Per Share TTM5.88
  • Gross Profit TTM 109.20M
  • Diluted EPS TTM0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -4.46900M -9.59500M -35.89600M -23.73500M -18.30100M
Minority interest - - - - -
Net income -4.50100M -5.40500M -34.35300M -22.73000M -18.18300M
Selling general administrative 32.75M 30.66M 34.43M 25.13M 20.68M
Selling and marketing expenses - 46.83M - - -
Gross profit 108.06M 84.72M 109.93M 75.28M 47.05M
Reconciled depreciation 19.19M 19.98M 20.07M 15.39M 11.46M
Ebit 4.71M 4.67M 7.91M 4.71M -2.93800M
Ebitda 23.90M 24.65M 27.98M 20.11M 8.52M
Depreciation and amortization 19.19M 19.98M 20.07M 15.39M 11.46M
Non operating income net other - - - - -
Operating income 4.53M 4.67M 7.91M 4.71M -2.93800M
Other operating expenses 362.19M 366.08M 374.09M 257.82M 163.61M
Interest expense 9.18M 14.27M 15.22M 14.49M 1.22M
Tax provision 0.03M -4.19000M -1.54300M -1.00500M -0.11800M
Interest income 9.12M 1.26M 0.28M 16.83M 4.92M
Net interest income -9.11900M -13.01300M -14.94300M -14.58900M -2.95200M
Extraordinary items - - - 0.00000M -0.07900M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.03M -4.19000M -1.54300M -1.00500M -0.11800M
Total revenue 366.71M 370.75M 381.73M 262.63M 162.20M
Total operating expenses 103.53M 100.03M 102.30M 70.47M 48.46M
Cost of revenue 258.65M 286.02M 271.79M 187.35M 115.14M
Total other income expense net -8.99400M -14.26500M -43.80700M -28.44900M -15.36300M
Discontinued operations - - - - -0.07900M
Net income from continuing ops -4.50100M -5.40500M -34.35300M -22.73000M -18.18300M
Net income applicable to common shares -4.50100M -5.40500M -34.35300M -22.73000M -18.26200M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 223.54M 231.89M 264.54M 282.82M 156.11M
Intangible assets 34.30M 44.33M 52.95M 54.57M 35.33M
Earning assets - - - - -
Other current assets 1.95M 1.96M 2.56M 3.52M 1.64M
Total liab 139.31M 150.37M 200.08M 200.53M 144.81M
Total stockholder equity 84.23M 81.53M 64.46M 82.29M 11.30M
Deferred long term liab - - - - -
Other current liab 1.19M 20.97M 23.40M 18.50M 20.86M
Common stock - 323.30M 299.78M 283.46M 189.78M
Capital stock 331.11M 323.30M 299.78M 283.46M 189.78M
Retained earnings -287.18900M -282.68800M -277.28300M -242.93000M -220.20000M
Other liab - - 10.97M 17.39M 21.73M
Good will 70.01M 70.01M 70.01M 92.11M 51.74M
Other assets - - - - -
Cash 9.08M 7.71M 28.37M 35.62M 19.62M
Cash and equivalents - - 28.37M 35.62M 19.62M
Total current liabilities 62.80M 62.45M 63.89M 52.97M 43.35M
Current deferred revenue - - - - 17.32M
Net debt 36.20M 89.81M 106.85M 89.95M 62.57M
Short term debt - 12.37M 10.01M 1.27M 6.08M
Short long term debt 5.33M 9.92M 7.41M 0.73M 4.25M
Short long term debt total - 97.52M 135.22M 125.57M 82.19M
Other stockholder equity - 33.62M 41.96M 41.76M 41.73M
Property plant equipment - - 52.39M 38.17M 21.14M
Total current assets 62.34M 65.41M 89.18M 95.25M 45.19M
Long term investments - - 0.00000M 2.71M 2.71M
Net tangible assets - - -58.50900M -64.40000M -75.76400M
Short term investments - - - - -
Net receivables 32.43M 36.09M 37.26M 38.11M 15.35M
Long term debt 39.96M 57.15M 99.37M 111.97M 71.95M
Inventory 17.67M 19.66M 20.30M 17.99M 8.58M
Accounts payable 31.83M 29.11M 30.48M 33.21M 16.41M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 7.30M - - -18.38300M
Additional paid in capital - - - - -
Common stock total equity - - - - 189.78M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 161.20M 166.48M 175.36M 187.57M 110.92M
Capital lease obligations 37.34M 30.79M 28.44M 18.73M 9.62M
Long term debt total - - 125.22M 130.16M 79.72M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -7.91800M -12.31400M -16.59800M -93.17700M -4.17100M
Change to liabilities - - 0.82M 15.00M -2.76500M
Total cashflows from investing activities -7.91800M -12.31400M -16.59800M -93.17700M -4.17100M
Net borrowings -21.58200M -39.82400M -5.28900M 30.35M 18.54M
Total cash from financing activities -28.01800M -36.40300M -12.98900M 101.91M 23.50M
Change to operating activities - - 0.31M -5.16900M 3.57M
Net income -4.50100M -5.40500M -34.35300M -22.73000M -18.26200M
Change in cash 2.06M -21.34200M -7.25400M 16.00M 19.56M
Begin period cash flow 7.03M 29.05M 35.62M 19.62M 0.06M
End period cash flow 9.08M 7.71M 28.37M 35.62M 19.62M
Total cash from operating activities 37.99M 27.38M 22.33M 7.27M 0.23M
Issuance of capital stock 0.00000M 14.68M 1.01M 80.86M 0.00000M
Depreciation 19.19M 19.98M 20.07M 15.39M 11.46M
Other cashflows from investing activities -2.52600M -3.92800M -2.98500M -86.06100M -0.07400M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory 1.55M 0.65M -1.99700M -2.83300M 0.49M
Change to account receivables 3.82M 1.47M 1.51M -10.72100M 2.54M
Sale purchase of stock -0.80100M -0.05600M 1.01M 80.86M -
Other cashflows from financing activities -5.63500M -11.20200M -8.70700M 51.69M 42.49M
Change to netincome - - 35.98M 18.33M 3.35M
Capital expenditures 8.11M 8.70M 13.61M 7.12M 1.96M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 8.98M 2.12M 0.64M -3.72700M 3.69M
Stock based compensation 3.65M 1.47M 4.57M 2.67M 2.52M
Other non cash items 10.64M 13.40M 32.96M 16.67M 1.00M
Free cash flow 29.88M 18.68M 8.72M 0.15M -1.72600M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRRX
CareRx Corp		 -0.04 1.10% 3.60 390.00 20.00 0.67 2.81 0.85 11.90
EXE
Extendicare Inc		 0.46 1.76% 26.64 22.84 21.74 1.44 13.77 1.53 13.80
SIA
Sienna Senior Living Inc		 0.02 0.09% 23.05 50.39 38.02 2.16 3.33 3.42 22.17
WELL
WELL Health Technologies Corp		 -0.09 2.04% 4.33 - 10.52 0.79 1.23 1.23 13.24
DR
Medical Facilities Corporation		 -0.17 1.00% 16.80 6.14 9.86 0.89 2.50 0.70 3.08

Reports Covered

Stock Research & News

View All

Profile

CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company offers medication management, technology, and program services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.

CareRx Corp

320 Bay Street, Toronto, ON, Canada, M5H 4A6

Key Executives

Name Title Year Born
Mr. David Murphy Pres, CEO & Director NA
Mr. Andrew Mok Chief Financial Officer NA
Mr. Puneet Khanna Chief Operating Officer NA
Mr. Paul Rakowski Sr. VP of Corp. Devel., Gen. Counsel, Chief Privacy Officer and Corp. Sec. NA
Ms. Adrianne Sullivan Campeau Chief People & Culture Officer NA
Mr. Ryan Stempfle VP & GM of Western Canada for the Specialty Pharmacy Division NA
Mr. Puneet Khanna CEO, President & Director NA
Mr. Paul Rakowski Senior VP of Corporate Development, General Counsel, Chief Privacy Officer & Corporate Secretary NA
Mr. Travis Featherstone Senior VP of Western Operations & System Integration NA
Ms. Suzanne Brand Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.